189 related articles for article (PubMed ID: 23352980)
1. PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells.
Kim W; Youn H; Kwon T; Kang J; Kim E; Son B; Yang HJ; Jung Y; Youn B
Pharmacol Res; 2013 Apr; 70(1):90-101. PubMed ID: 23352980
[TBL] [Abstract][Full Text] [Related]
2. PIM1-activated PRAS40 regulates radioresistance in non-small cell lung cancer cells through interplay with FOXO3a, 14-3-3 and protein phosphatases.
Kim W; Youn H; Seong KM; Yang HJ; Yun YJ; Kwon T; Kim YH; Lee JY; Jin YW; Youn B
Radiat Res; 2011 Nov; 176(5):539-52. PubMed ID: 21910584
[TBL] [Abstract][Full Text] [Related]
3. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.
Kang J; Kim E; Kim W; Seong KM; Youn H; Kim JW; Kim J; Youn B
J Biol Chem; 2013 Sep; 288(38):27343-27357. PubMed ID: 23902763
[TBL] [Abstract][Full Text] [Related]
4. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells.
Kim W; Youn H; Kang C; Youn B
Apoptosis; 2015 Sep; 20(9):1242-52. PubMed ID: 26033480
[TBL] [Abstract][Full Text] [Related]
5. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.
Gao H; Xue J; Zhou L; Lan J; He J; Na F; Yang L; Deng L; Lu Y
Cancer Lett; 2015 Aug; 365(1):79-88. PubMed ID: 25982206
[TBL] [Abstract][Full Text] [Related]
7. Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis.
Chen F; Xu C; Du L; Wang Y; Cao J; Fu Y; Guo Y; Liu Q; Fan F
Int J Oncol; 2013 Mar; 42(3):985-92. PubMed ID: 23338568
[TBL] [Abstract][Full Text] [Related]
8. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
[TBL] [Abstract][Full Text] [Related]
9. Luteolin acts as a radiosensitizer in non‑small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38/ROS/caspase cascade.
Cho HJ; Ahn KC; Choi JY; Hwang SG; Kim WJ; Um HD; Park JK
Int J Oncol; 2015 Mar; 46(3):1149-58. PubMed ID: 25586525
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of insulin-like growth factor 1 receptor by CP-751,871 radiosensitizes non-small cell lung cancer cells.
Iwasa T; Okamoto I; Suzuki M; Hatashita E; Yamada Y; Fukuoka M; Ono K; Nakagawa K
Clin Cancer Res; 2009 Aug; 15(16):5117-25. PubMed ID: 19671857
[TBL] [Abstract][Full Text] [Related]
11. Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3.
Kim BM; Won J; Maeng KA; Han YS; Yun YS; Hong SH
Int J Oncol; 2009 May; 34(5):1467-73. PubMed ID: 19360361
[TBL] [Abstract][Full Text] [Related]
12. MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A.
Li H; Jiang M; Cui M; Feng G; Dong J; Li Y; Xiao H; Fan S
Biochem Biophys Res Commun; 2019 Apr; 512(2):392-398. PubMed ID: 30902389
[TBL] [Abstract][Full Text] [Related]
13. c-Myc down-regulation is involved in proteasome inhibitor-mediated enhancement of radiotherapeutic efficacy in non-small cell lung cancer.
Jung J; Kim EJ; Chung HK; Park HJ; Jeong SY; Choi EK
Int J Oncol; 2012 Feb; 40(2):385-90. PubMed ID: 21947247
[TBL] [Abstract][Full Text] [Related]
14. The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death.
Kim KW; Speirs CK; Jung DK; Lu B
J Thorac Oncol; 2011 Sep; 6(9):1542-52. PubMed ID: 21642866
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
16. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells.
Raghavan P; Tumati V; Yu L; Chan N; Tomimatsu N; Burma S; Bristow RG; Saha D
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e507-14. PubMed ID: 22795803
[TBL] [Abstract][Full Text] [Related]
17. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
[TBL] [Abstract][Full Text] [Related]
18. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway.
Lei Y; Li HX; Jin WS; Peng WR; Zhang CJ; Bu LJ; Du YY; Ma T; Sun GP
Int J Radiat Biol; 2013 Dec; 89(12):1079-86. PubMed ID: 23875954
[TBL] [Abstract][Full Text] [Related]
19. DANGER is involved in high glucose-induced radioresistance through inhibiting DAPK-mediated anoikis in non-small cell lung cancer.
Kwon T; Youn H; Son B; Kim D; Seong KM; Park S; Kim W; Youn B
Oncotarget; 2016 Feb; 7(6):7193-206. PubMed ID: 26769850
[TBL] [Abstract][Full Text] [Related]
20. β-Apopicropodophyllin functions as a radiosensitizer targeting ER stress in non-small cell lung cancer.
Kim JY; Cho JH; Kim EM; Shin HJ; Hwang SG; Song JY; Um HD; Park JK
Biomed Pharmacother; 2019 May; 113():108769. PubMed ID: 30870718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
